Influence of Ukrain on immunological blood parameters in vitro and in vivo.
Immunological changes are often seen in subjects suffering from oncological disease. Decreased NK activity, alterations of the T4/T8 quotient, decreased phagocytic activity, low reactivity and decreased recognition of the "foreign" are common features seen in these patients. Cytostatic therapy (chemotherapy and radiation therapy) very often enhance these negative properties, thus limiting therapeutic possibilities by highly toxic sequels. Ukrain, being cytostatic and immune-stimulating and modulating, has no adverse effects on the organism.
Nowicky
J W
JW
Ukrainian Anti-Cancer Institute, Vienna, Austria.
Hiesmayr
W
W
Liepins
A
A
D000470:Alkaloids / Q000494:pharmacology*; D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D001600:Berberine Alkaloids; D004357:Drug Synergism; D005260:Female; D006098:Granulocytes / Q000187:drug effects* / Q000276:immunology*; D007694:Killer Cells, Natural / Q000187:drug effects / Q000276:immunology; D008213:Lymphocyte Activation; D008297:Male; D010617:Phenanthridines; D010835:Phytohemagglutinins / Q000494:pharmacology; D051381:Rats; D017208:Rats, Wistar; D017701:Reticulocyte Count / Q000187:drug effects; D012156:Reticulocytes / Q000166:cytology / Q000187:drug effects* / Q000276:immunology*; D013601:T-Lymphocytes / Q000187:drug effects* / Q000276:immunology*; D013852:Thiotepa / Q000627:therapeutic use
D000470:Alkaloids; D000970:Antineoplastic Agents; D001600:Berberine Alkaloids; D010617:Phenanthridines; D010835:Phytohemagglutinins; C060921:ukrain; D013852:Thiotepa